Nektar Therapeutics (NKTR) Tax Provisions (2010 - 2026)
Nektar Therapeutics (NKTR) recorded quarterly Tax Provisions of $64000.0 in Q1 2026, up 106.45% quarter-over-quarter from $31000.0 in Q4 2025, and up 23.08% on a YoY basis from $52000.0 in Q1 2025.
Nektar Therapeutics (NKTR) Tax Provisions (2010 - 2026) Analysis & Trends
Nektar Therapeutics' Tax Provisions history runs 17 years deep, the most recent figure standing at $64000.0 for Q1 2026.
- In Q1 2026, Tax Provisions rose 23.08% year-over-year to $64000.0; the TTM figure through Mar 2026 stood at -$126000.0 (up 11.27% YoY), while the FY2025 annual figure was -$138000.0, up 39.74% from the prior year.
- Tax Provisions was $64000.0 for Q1 2026 at Nektar Therapeutics, up from $31000.0 in the prior quarter.
- In the past five years, Tax Provisions ranged from a high of $3.1 million in Q4 2022 to a low of -$249000.0 in Q4 2024.
- Historically, Tax Provisions has averaged $167764.7 across 5 years, with a median of $9000.0 in 2024.
- The sharpest annual moves came in 2022 and 2025: Tax Provisions soared 78700.0% in 2022, then tumbled 508.7% in 2025.
- A 5-year view of Tax Provisions shows it stood at $3.1 million in 2022, then plunged by 96.47% to $111000.0 in 2023, then slumped by 324.32% to -$249000.0 in 2024, then surged by 112.45% to $31000.0 in 2025, then jumped by 106.45% to $64000.0 in 2026.
- The last three Tax Provisions figures came in at $64000.0 (Q1 2026), $31000.0 (Q4 2025), and -$33000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -11.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 216,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -859,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 221.50 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Nektar Therapeutics | 1.51 Bn | 939.55 Mn | 3.16 Mn | 64,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 64,000.00 |
| Dec 31, 2025 | 31,000.00 |
| Sep 30, 2025 | -33,000.00 |
| Jun 30, 2025 | -188,000.00 |
| Mar 31, 2025 | 52,000.00 |
| Dec 31, 2024 | -249,000.00 |
| Sep 30, 2024 | 9,000.00 |
| Jun 30, 2024 | 46,000.00 |
| Mar 31, 2024 | -35,000.00 |
| Dec 31, 2023 | 111,000.00 |
| Sep 30, 2023 | -61,000.00 |
| Jun 30, 2023 | -47,000.00 |
| Mar 31, 2023 | -63,000.00 |
| Dec 31, 2022 | 3.14 Mn |
| Sep 30, 2022 | -155,000.00 |
| Jun 30, 2022 | 100,000.00 |
| Mar 31, 2022 | 126,000.00 |
| Dec 31, 2021 | -4,000.00 |
| Sep 30, 2021 | 112,000.00 |
| Jun 30, 2021 | 357,000.00 |